Putnam Investments LLC Cara Therapeutics, Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $6,328 - $9,646	-768 Reduced 1.74%	43,448 $407,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $286,169 - $531,622	-38,412 Reduced 46.49%	44,216 $404,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $63,695 - $81,061	-6,408 Reduced 7.2%	82,628 $1 Million
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $1.07 Million - $1.62 Million	89,036 New	89,036 $1.09 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.